Literature DB >> 27346144

Safety of supramesocolic surgery in patients with portal cavernoma without portal vein decompression. Large single centre experience.

Safi Dokmak1, Béatrice Aussilhou2, Alain Sauvanet2, Philippe Lévy3, Aurélie Plessier4, Fadhel S Ftériche2, Olivier Farges2, Valérie Vilgrain5, Dominique C Valla4, Jacques Belghiti2.   

Abstract

BACKGROUND: Supra-mesocolic surgery (SMS) is complicated in patients with portal vein cavernoma (PC) and portal decompression is recommended. The aim of this study was to report a large single centre of SMS in patients with PC without portal decompression.
METHODS: Between 2006 and 2013, all patients who met inclusion criteria were analyzed retrospectively. The primary endpoint was the feasibility rate, surgical and postoperative outcome. The secondary endpoints were the long-term outcome of patients who underwent biliary bypass for cholangitis. Risk factors for complications were studied.
RESULTS: Thirty patients underwent 51 procedures. Pancreatitis was the main etiology of PC (19/30) and biliary obstruction was mainly related to the underlying disease and not to portal cholangiopathy (12/14). All planned procedures were successfully completed. Fourteen patients underwent biliary bypass. Median blood loss (250 ml), transfusion (n = 7), mortality (n = 0), overall morbidity (n = 12) and the median hospital stay (10 days). Good long-term control of cholangitis was achieved in the 9 patients alive with available follow-up. Significant risk factors for complications were a previous abdominal wall scar, previous intra-abdominal surgical field and liver fibrosis.
CONCLUSION: SMS can be safely performed in patients with PC. In patients with risk factors for complications, portal decompression should be discussed.
Copyright © 2016 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27346144      PMCID: PMC4925800          DOI: 10.1016/j.hpb.2016.05.009

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  36 in total

1.  Portal biliopathy treated by liver transplantation.

Authors:  Franco Filipponi; Lucio Urbani; Gabriele Catalano; Giuseppe Iaria; Gianni Biancofiore; Roberto Cioni; Alessandro Campatelli; Franco Mosca; Daniela Campani; Paolo Romagnoli
Journal:  Transplantation       Date:  2004-01-27       Impact factor: 4.939

2.  Cavernous transformation of the portal vein.

Authors:  J B GIBSON; R L RICHARDS
Journal:  J Pathol Bacteriol       Date:  1955-07

3.  Sump syndrome as a complication of choledochoduodenostomy.

Authors:  Motaz Qadan; Sharon Clarke; Ellen Morrow; George Triadafilopoulos; Brendan Visser
Journal:  Dig Dis Sci       Date:  2011-12-14       Impact factor: 3.199

4.  Which treatment to choose for portal biliopathy with extensive portal thrombosis?

Authors:  Antoine Camerlo; Regis Fara; Louise Barbier; Emilie Grégoire; Yves Patrice Le Treut
Journal:  Dig Surg       Date:  2010-10-13       Impact factor: 2.588

5.  Therapeutic strategies in symptomatic portal biliopathy.

Authors:  Eric Vibert; Daniel Azoulay; Thomas Aloia; Gérard Pascal; Luc-Antoine Veilhan; René Adam; Didier Samuel; Denis Castaing
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

Review 6.  Endoscopic management of portal cavernoma cholangiopathy: practice, principles and strategy.

Authors:  Vivek A Saraswat; Praveer Rai; Tarun Kumar; Samir Mohindra; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-10-22

7.  Common bile duct obstruction by portal cavernoma.

Authors:  G Choudhuri; R K Tandon; S Nundy; N K Misra
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

8.  [Portal vein thrombosis associated with a myeloproliferative disorder, prothrombin G20210A mutation, antiphospholipid syndrome, with repermeation during anticoagulant therapy].

Authors:  E Diaz; S Nahon; A Charachon; L Traissac; M Lenoble; E Challier; N Delas
Journal:  Gastroenterol Clin Biol       Date:  2001-05

9.  Pseudosclerosing cholangitis in extrahepatic portal venous obstruction.

Authors:  J B Dilawari; Y K Chawla
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

10.  The "pseudo-cholangiocarcinoma sign" in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels.

Authors:  Y Bayraktar; F Balkanci; A Ozenc; S Arslan; T Koseoglu; A Ozdemir; B Uzunalimoglu; H Telatar; A Gurakar; D H Van Thiel
Journal:  Am J Gastroenterol       Date:  1995-11       Impact factor: 10.864

View more
  2 in total

Review 1.  Optimal Treatment for Patients With Cavernous Transformation of the Portal Vein.

Authors:  Bo Wei; Zhiyin Huang; Chengwei Tang
Journal:  Front Med (Lausanne)       Date:  2022-03-24

2.  Laparoscopic cholecystectomy in patients with portal cavernoma without portal vein decompression.

Authors:  Shridhar Vasantrao Sasturkar; Nikhil Agrawal; Asit Arora; M P Senthil Kumar; Ragini Kilambi; Shalini Thapar; Tushar Kanti Chattopadhyay
Journal:  J Minim Access Surg       Date:  2021 Jul-Sep       Impact factor: 1.407

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.